Neuraxis, INC (NRXS) Form 10-K Annual Reports
Neuraxis, INC (NRXS) is a publicly traded company on the NYSE, categorized under SIC 3845 (Electromedical & Electrotherapeutic Apparatus). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: NRXS
CIK: 1933567
Exchange: NYSE
SIC 3845: Electromedical & Electrotherapeutic Apparatus
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Rosenberg Rich Baker Berman, P.A.
Auditor SinceSince 12/31/2021 12:00:00 AM
Lead Engagement PartnerHoward Condo
Audit LocationSomerset, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-14 | 2026-10-14 | 8-K | 0001493152-26-047034 | View SEC Doc Filr Page |
| 4 | 2026-10-08 | 2026-10-08 | 4 | 0001493152-26-046382 | View SEC Doc Filr Page |
| 4 | 2026-10-08 | 2026-10-08 | 4 | 0001493152-26-046381 | View SEC Doc Filr Page |
| 4 | 2026-10-08 | 2026-10-08 | 4 | 0001493152-26-046380 | View SEC Doc Filr Page |
| 3 | 2026-09-29 | 2026-09-28 | 3 | 0001493152-26-044807 | View SEC Doc Filr Page |
| 4 | 2026-08-26 | 2026-08-24 | 4 | 0001493152-26-040275 | View SEC Doc Filr Page |
| 4 | 2026-08-26 | 2026-08-24 | 4 | 0001493152-26-040276 | View SEC Doc Filr Page |
| 4 | 2026-08-26 | 2026-08-24 | 4 | 0001493152-26-040274 | View SEC Doc Filr Page |
| 8-K | 2026-08-19 | 2026-07-24 | 8-K | 0001493152-26-039247 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-13 | 4 | 0001493152-26-038831 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-13 | 4 | 0001493152-26-038829 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-13 | 4 | 0001493152-26-038827 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-13 | 4 | 0001493152-26-038824 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-13 | 4 | 0001493152-26-038821 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-13 | 4 | 0001493152-26-038819 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-13 | 4 | 0001493152-26-038817 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-13 | 4 | 0001493152-26-038815 | View SEC Doc Filr Page |
| 10-Q | 2026-08-11 | 2026-06-30 | 10-Q | 0001493152-26-036978 | View SEC Doc Filr Page |
| 424B3 | 2026-08-06 | — | 424B3 | 0001493152-26-036227 | View SEC Doc Filr Page |
| EFFECT | 2026-08-03 | — | EFFECT Filing | 9999999995-26-002528 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-03 | — | SCHEDULE 13G/A Filing | 0000921895-26-001926 | View SEC Doc Filr Page |
| S-3/A | 2026-07-30 | — | S-3/A | 0001493152-26-035433 | View SEC Doc Filr Page |
| S-3 | 2026-07-23 | — | S-3 | 0001493152-26-034417 | View SEC Doc Filr Page |
| S-8 | 2026-07-10 | — | S-8 | 0001493152-26-032829 | View SEC Doc Filr Page |
| 8-K | 2026-07-10 | 2026-07-09 | 8-K | 0001493152-26-032769 | View SEC Doc Filr Page |